vs

Side-by-side financial comparison of Dole plc (DOLE) and Emerson Electric (EMR). Click either name above to swap in a different company.

Emerson Electric is the larger business by last-quarter revenue ($4.3B vs $2.3B, roughly 1.9× Dole plc). Emerson Electric runs the higher net margin — 13.9% vs 0.2%, a 13.7% gap on every dollar of revenue. On growth, Dole plc posted the faster year-over-year revenue change (10.5% vs 4.1%). Emerson Electric produced more free cash flow last quarter ($602.0M vs $66.5M). Over the past eight quarters, Dole plc's revenue compounded faster (3.2% CAGR vs -0.3%).

Dole plc is an Irish-American agricultural multinational corporation headquartered in Dublin, Ireland. The company is among the world's largest producers of fruit and vegetables, operating with 38,500 full-time and seasonal employees who supply some 300 products in 75 countries. Dole reported 2021 revenues of $6.5 billion.

Emerson Electric Co. is an American multinational corporation headquartered in St. Louis, Missouri. The Fortune 500 company delivers a range of engineering services, manufactures industrial automation equipment, climate control systems, and precision measurement instruments, and provides software engineering for industrial, commercial, and consumer markets.

DOLE vs EMR — Head-to-Head

Bigger by revenue
EMR
EMR
1.9× larger
EMR
$4.3B
$2.3B
DOLE
Growing faster (revenue YoY)
DOLE
DOLE
+6.4% gap
DOLE
10.5%
4.1%
EMR
Higher net margin
EMR
EMR
13.7% more per $
EMR
13.9%
0.2%
DOLE
More free cash flow
EMR
EMR
$535.5M more FCF
EMR
$602.0M
$66.5M
DOLE
Faster 2-yr revenue CAGR
DOLE
DOLE
Annualised
DOLE
3.2%
-0.3%
EMR

Income Statement — Q3 FY2025 vs Q1 FY2026

Metric
DOLE
DOLE
EMR
EMR
Revenue
$2.3B
$4.3B
Net Profit
$5.1M
$605.0M
Gross Margin
6.8%
53.2%
Operating Margin
1.1%
17.8%
Net Margin
0.2%
13.9%
Revenue YoY
10.5%
4.1%
Net Profit YoY
-64.6%
3.4%
EPS (diluted)
$0.05
$1.07

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
DOLE
DOLE
EMR
EMR
Q4 25
$4.3B
Q3 25
$2.3B
$4.9B
Q2 25
$2.4B
$4.6B
Q1 25
$2.1B
$4.4B
Q4 24
$4.2B
Q3 24
$2.1B
$4.6B
Q2 24
$2.1B
$4.4B
Q1 24
$2.1B
$4.4B
Net Profit
DOLE
DOLE
EMR
EMR
Q4 25
$605.0M
Q3 25
$5.1M
$637.0M
Q2 25
$10.0M
$586.0M
Q1 25
$38.9M
$485.0M
Q4 24
$585.0M
Q3 24
$14.4M
$996.0M
Q2 24
$80.1M
$329.0M
Q1 24
$70.1M
$501.0M
Gross Margin
DOLE
DOLE
EMR
EMR
Q4 25
53.2%
Q3 25
6.8%
51.9%
Q2 25
9.0%
52.6%
Q1 25
8.7%
53.5%
Q4 24
53.5%
Q3 24
8.0%
51.3%
Q2 24
9.4%
52.8%
Q1 24
9.2%
52.2%
Operating Margin
DOLE
DOLE
EMR
EMR
Q4 25
17.8%
Q3 25
1.1%
16.4%
Q2 25
4.3%
16.1%
Q1 25
3.2%
14.2%
Q4 24
18.6%
Q3 24
2.3%
14.7%
Q2 24
4.0%
10.4%
Q1 24
5.3%
16.2%
Net Margin
DOLE
DOLE
EMR
EMR
Q4 25
13.9%
Q3 25
0.2%
13.1%
Q2 25
0.4%
12.9%
Q1 25
1.9%
10.9%
Q4 24
14.0%
Q3 24
0.7%
21.6%
Q2 24
3.8%
7.5%
Q1 24
3.3%
11.4%
EPS (diluted)
DOLE
DOLE
EMR
EMR
Q4 25
$1.07
Q3 25
$0.05
$1.12
Q2 25
$0.10
$1.04
Q1 25
$0.41
$0.86
Q4 24
$1.02
Q3 24
$0.15
$1.74
Q2 24
$0.84
$0.57
Q1 24
$0.74
$0.87

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
DOLE
DOLE
EMR
EMR
Cash + ST InvestmentsLiquidity on hand
$321.0M
Total DebtLower is stronger
$7.6B
Stockholders' EquityBook value
$1.4B
$20.3B
Total Assets
$4.5B
$41.9B
Debt / EquityLower = less leverage
0.37×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
DOLE
DOLE
EMR
EMR
Q4 25
Q3 25
$321.0M
Q2 25
$323.1M
Q1 25
$261.0M
Q4 24
Q3 24
$266.4M
Q2 24
$225.8M
Q1 24
$245.5M
Total Debt
DOLE
DOLE
EMR
EMR
Q4 25
$7.6B
Q3 25
$8.9B
Q2 25
$8.3B
Q1 25
$8.2B
Q4 24
$6.6B
Q3 24
$7.7B
Q2 24
$7.1B
Q1 24
$7.6B
Stockholders' Equity
DOLE
DOLE
EMR
EMR
Q4 25
$20.3B
Q3 25
$1.4B
$20.3B
Q2 25
$1.4B
$19.9B
Q1 25
$1.3B
$19.2B
Q4 24
$20.5B
Q3 24
$1.4B
$21.6B
Q2 24
$1.4B
$20.8B
Q1 24
$1.3B
$20.9B
Total Assets
DOLE
DOLE
EMR
EMR
Q4 25
$41.9B
Q3 25
$4.5B
$42.0B
Q2 25
$4.7B
$42.5B
Q1 25
$4.5B
$42.0B
Q4 24
$42.6B
Q3 24
$4.5B
$44.2B
Q2 24
$4.4B
$45.6B
Q1 24
$4.5B
$46.4B
Debt / Equity
DOLE
DOLE
EMR
EMR
Q4 25
0.37×
Q3 25
0.44×
Q2 25
0.42×
Q1 25
0.42×
Q4 24
0.32×
Q3 24
0.36×
Q2 24
0.34×
Q1 24
0.36×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
DOLE
DOLE
EMR
EMR
Operating Cash FlowLast quarter
$87.4M
$699.0M
Free Cash FlowOCF − Capex
$66.5M
$602.0M
FCF MarginFCF / Revenue
2.9%
13.9%
Capex IntensityCapex / Revenue
0.9%
2.2%
Cash ConversionOCF / Net Profit
17.12×
1.16×
TTM Free Cash FlowTrailing 4 quarters
$13.7M
$4.4B

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
DOLE
DOLE
EMR
EMR
Q4 25
$699.0M
Q3 25
$87.4M
$3.1B
Q2 25
$18.3M
$1.1B
Q1 25
$-78.8M
$241.0M
Q4 24
$777.0M
Q3 24
$101.0M
$3.3B
Q2 24
$40.2M
$1.1B
Q1 24
$-35.0M
$743.0M
Free Cash Flow
DOLE
DOLE
EMR
EMR
Q4 25
$602.0M
Q3 25
$66.5M
$2.7B
Q2 25
$-1.0M
$977.0M
Q1 25
$-131.6M
$154.0M
Q4 24
$694.0M
Q3 24
$79.9M
$2.9B
Q2 24
$22.8M
$998.0M
Q1 24
$-53.2M
$661.0M
FCF Margin
DOLE
DOLE
EMR
EMR
Q4 25
13.9%
Q3 25
2.9%
54.9%
Q2 25
-0.0%
21.5%
Q1 25
-6.3%
3.5%
Q4 24
16.6%
Q3 24
3.9%
63.1%
Q2 24
1.1%
22.8%
Q1 24
-2.5%
15.1%
Capex Intensity
DOLE
DOLE
EMR
EMR
Q4 25
2.2%
Q3 25
0.9%
8.9%
Q2 25
0.8%
2.0%
Q1 25
2.5%
2.0%
Q4 24
2.0%
Q3 24
1.0%
9.1%
Q2 24
0.8%
2.1%
Q1 24
0.9%
1.9%
Cash Conversion
DOLE
DOLE
EMR
EMR
Q4 25
1.16×
Q3 25
17.12×
4.86×
Q2 25
1.84×
1.83×
Q1 25
-2.02×
0.50×
Q4 24
1.33×
Q3 24
7.01×
3.35×
Q2 24
0.50×
3.31×
Q1 24
-0.50×
1.48×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

DOLE
DOLE

Segment breakdown not available.

EMR
EMR

Other$1.8B41%
Software And Systems$1.0B24%
Intelligent Devices$996.0M23%
Safety And Productivity$503.0M12%

Related Comparisons